AI & Computational Biology With Recursion's Chris Gibson, Ph.D.

Source: Bioprocess Online

Recursion's unique, technology-aided approach to drug discovery has yielded one of the deepest, fastest-growing pipelines in emerging biotech. It starts with a 20-petabyte-and-growing database designed to create comprehensive "maps of biology" that enable insight into the relationships between molecules and cell types. On this episode of the Business of Biotech, we take a deep dive into the approach—and what Recursion intends to do with all that data—with the company's co-founder and CEO, Chris Gibson, Ph.D. Don't miss this window into the world of a true pioneer in computational biology.



access the Podcast!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Drug Discovery Online